IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.697
+0.019 (2.74%)
At close: Dec 5, 2025, 4:00 PM EST
0.714
+0.017 (2.45%)
After-hours: Dec 5, 2025, 7:59 PM EST
IO Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 24.14 | 23.69 | 23.61 | 24.44 | 11.08 | 1.68 | |
| Research & Development | 67.92 | 71.48 | 67.83 | 46.99 | 30.15 | 8.46 | |
| Operating Expenses | 92.05 | 95.18 | 91.44 | 71.42 | 41.23 | 10.15 | |
| Operating Income | -92.05 | -95.18 | -91.44 | -71.42 | -41.23 | -10.15 | |
| Interest Expense | -1.14 | - | - | -0.3 | -0.36 | -0.03 | |
| Interest & Investment Income | 1.68 | 4.72 | 5.88 | 1.41 | - | - | |
| Currency Exchange Gain (Loss) | -5.05 | -3.59 | 0.33 | 0.13 | 0.32 | 0.11 | |
| EBT Excluding Unusual Items | -89.3 | -94.05 | -85.23 | -70.19 | -41.28 | -10.06 | |
| Other Unusual Items | - | - | - | - | -26.54 | -1.99 | |
| Pretax Income | -89.3 | -94.05 | -85.23 | -70.19 | -67.81 | -12.04 | |
| Income Tax Expense | -0.96 | 1.44 | 0.85 | 1.27 | 0.07 | - | |
| Net Income | -88.35 | -95.49 | -86.08 | -71.46 | -67.88 | -12.04 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | 7.11 | 2.55 | |
| Net Income to Common | -88.35 | -95.49 | -86.08 | -71.46 | -74.99 | -14.59 | |
| Shares Outstanding (Basic) | 66 | 66 | 44 | 29 | 4 | 0 | |
| Shares Outstanding (Diluted) | 66 | 66 | 44 | 29 | 4 | 0 | |
| Shares Change (YoY) | 0.31% | 51.31% | 51.10% | 564.62% | 2346.74% | - | |
| EPS (Basic) | -1.34 | -1.45 | -1.98 | -2.48 | -17.30 | -82.36 | |
| EPS (Diluted) | -1.34 | -1.45 | -1.98 | -2.48 | -17.30 | -82.36 | |
| Free Cash Flow | -81.07 | -82.39 | -72.06 | -60.42 | -40.8 | -9.96 | |
| Free Cash Flow Per Share | -1.23 | -1.25 | -1.66 | -2.10 | -9.41 | -56.19 | |
| EBITDA | -91.8 | -94.92 | -91.23 | -71.32 | -41.23 | - | |
| D&A For EBITDA | 0.25 | 0.25 | 0.22 | 0.1 | 0 | - | |
| EBIT | -92.05 | -95.18 | -91.44 | -71.42 | -41.23 | -10.15 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.